Holdings
Octagon Capital Advisors LP
As of Sep 30, 2026, Octagon Capital Advisors LP reported 24 positions worth US$732M. Largest: Dianthus Therapeutics, Inc., Abivax SA and Definium Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | 1.69M | US$149M | −155K | Sep 30, 2026 |
| Abivax SA | 993K | US$98.3M | no change | Sep 30, 2026 |
| Definium Therapeutics, Inc. | 2.51M | US$95.6M | −439K | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 2.35M | US$75.2M | no change | Sep 30, 2026 |
| ArriVent BioPharma, Inc. | 2.14M | US$64.8M | +170K | Sep 30, 2026 |
| Taysha Gene Therapies, Inc. | 9.69M | US$47.2M | no change | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 2.41M | US$33.2M | new | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 205K | US$22.9M | −105K | Sep 30, 2026 |
| Disc Medicine, Inc. | 270K | US$17.7M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 630K | US$15.7M | new | Sep 30, 2026 |